Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $2.85 Million - $3.24 Million
-12,646 Reduced 45.31%
15,267 $3.66 Million
Q1 2023

May 11, 2023

BUY
$239.75 - $277.0 $133,061 - $153,735
555 Added 2.03%
27,913 $7.04 Million
Q4 2022

Feb 10, 2023

BUY
$241.42 - $282.29 $2.66 Million - $3.11 Million
11,015 Added 67.4%
27,358 $7.26 Million
Q3 2022

Nov 08, 2022

SELL
$247.06 - $1507.4 $3,211 - $19,596
-13 Reduced 0.08%
16,343 $4.22 Million
Q2 2022

Aug 09, 2022

BUY
$237.11 - $299.66 $81,091 - $102,483
342 Added 2.14%
16,356 $4.15 Million
Q1 2022

May 11, 2022

SELL
$257.27 - $315.76 $3.15 Million - $3.86 Million
-12,225 Reduced 43.29%
16,014 $4.7 Million
Q4 2021

Feb 09, 2022

SELL
$292.08 - $329.01 $77,109 - $86,858
-264 Reduced 0.93%
28,239 $9.29 Million
Q3 2021

Nov 09, 2021

BUY
$272.21 - $332.43 $409,131 - $499,642
1,503 Added 5.57%
28,503 $8.68 Million
Q2 2021

Jul 15, 2021

SELL
$225.08 - $271.69 $202,121 - $243,977
-898 Reduced 3.22%
27,000 $7.25 Million
Q1 2021

Apr 23, 2021

BUY
$212.38 - $245.9 $220,662 - $255,490
1,039 Added 3.87%
27,898 $6.28 Million
Q4 2020

Feb 24, 2021

SELL
$212.5 - $245.46 $42,500 - $49,092
-200 Reduced 0.74%
26,859 $5.97 Million
Q3 2020

Oct 23, 2020

SELL
$177.16 - $215.33 $34,900 - $42,420
-197 Reduced 0.72%
27,059 $5.83 Million
Q2 2020

Aug 04, 2020

BUY
$128.7 - $176.83 $642,856 - $883,265
4,995 Added 22.44%
27,256 $4.82 Million
Q1 2020

May 05, 2020

SELL
$121.39 - $169.05 $1.25 Million - $1.74 Million
-10,310 Reduced 31.65%
22,261 $3.08 Million
Q4 2019

Jan 31, 2020

SELL
$133.47 - $153.48 $9,075 - $10,436
-68 Reduced 0.21%
32,571 $5 Million
Q3 2019

Oct 21, 2019

BUY
$135.4 - $146.47 $1.04 Million - $1.12 Million
7,672 Added 30.73%
32,639 $4.71 Million
Q2 2019

Jul 19, 2019

SELL
$124.88 - $143.73 $3,746 - $4,311
-30 Reduced 0.12%
24,967 $3.57 Million
Q1 2019

Apr 10, 2019

SELL
$97.62 - $132.29 $469,064 - $635,653
-4,805 Reduced 16.12%
24,997 $3.3 Million
Q1 2019

Apr 09, 2019

SELL
$97.62 - $132.29 $8,688 - $11,773
-89 Reduced 0.3%
29,802 $3.79 Million
Q4 2018

Jan 15, 2019

BUY
$94.85 - $109.54 $462,298 - $533,897
4,874 Added 19.48%
29,891 $3.08 Million
Q3 2018

Oct 12, 2018

SELL
$98.13 - $108.9 $574,453 - $637,500
-5,854 Reduced 18.96%
25,017 $2.72 Million
Q2 2018

Aug 07, 2018

SELL
$96.1 - $103.24 $2.97 Million - $3.19 Million
-30,871 Reduced 50.0%
30,871 $3.05 Million
Q2 2018

Jul 17, 2018

BUY
$96.1 - $103.24 $2.96 Million - $3.18 Million
30,799 Added 99.53%
61,742 $6.09 Million
Q1 2018

Apr 20, 2018

SELL
$92.16 - $103.8 $4,331 - $4,878
-47 Reduced 0.15%
30,943 $3.03 Million
Q4 2017

Jan 12, 2018

BUY
$85.26 - $94.62 $2.64 Million - $2.93 Million
30,990
30,990 $2.88 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Broadleaf Partners, LLC Portfolio

Follow Broadleaf Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Broadleaf Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Broadleaf Partners, LLC with notifications on news.